{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:56:48Z","timestamp":1789059408234,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00428-013-1501-6","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T03:49:49Z","timestamp":1384228189000},"page":"61-68","source":"Crossref","is-referenced-by-count":86,"title":["Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology"],"prefix":"10.1007","volume":"464","author":[{"given":"G.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Mengoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barbareschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cantaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Migaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2011.08.005","volume":"32","author":"WD Travis","year":"2011","unstructured":"Travis WD (2011) Pathology of lung cancer. Clin Chest Med 32:669\u2013692","journal-title":"Clin Chest Med"},{"key":"1501_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-60049-4","volume-title":"Histological typing of lung and pleural tumours","author":"W Travis","year":"1999","unstructured":"Travis W, Colby T, Corrin B, Shimosato Y, Brambilla E (1999) Histological typing of lung and pleural tumours. Springer, Heidelberg"},{"key":"1501_CR3","volume-title":"Tumours of the lung, pleura, thymus and heart","author":"W Travis","year":"2004","unstructured":"Travis W, Brambilla E, Muller-Hermelink H, Harris C (2004) Tumours of the lung, pleura, thymus and heart. IARC Press, Lyon"},{"key":"1501_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"W Travis","year":"2011","unstructured":"Travis W, Brambilla E, Noguchi M, Nicholson A, Geisinger K, Yatabe Y, Beer D, Powell C, Riely G, Van Schil P, Garg K, Austin J et al (2011) International association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244\u2013285","journal-title":"J Thorac Oncol"},{"key":"1501_CR5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.5858\/arpa.2012-0263-RA","volume":"137","author":"WD Travis","year":"2013","unstructured":"Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y, Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM, Petersen I, Roggli V, Thunnissen E, Tsao M (2013) Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification. Arch Pathol Lab Med 137:668\u2013684","journal-title":"Arch Pathol Lab Med"},{"key":"1501_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0031-1272866","volume":"32","author":"WD Travis","year":"2011","unstructured":"Travis WD, Rekhtman N (2011) Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. Semin Respir Crit Care Med 32:22\u201331","journal-title":"Semin Respir Crit Care Med"},{"key":"1501_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JTO.0b013e3181d57f6e","volume":"5","author":"WD Travis","year":"2010","unstructured":"Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E, Garg K, Hirsch FR, Noguchi M, Powell CA, Rusch VW, Scagliotti G, Yatabe Y (2010) Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol 5:411\u2013414","journal-title":"J Thorac Oncol"},{"key":"1501_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2011.10.017","volume":"76","author":"E Thunnissen","year":"2012","unstructured":"Thunnissen E, Kerr KM, Herth FJ, Lantuejoul S, Papotti M, Rintoul RC, Rossi G, Skov BG, Weynand B, Bubendorf L, Katrien G, Johansson L, Lopez-Rios F, Ninane V, Olszewski W, Popper H, Jaume S, Schnabel P, Thiberville L, Laenger F (2012) The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 76:1\u201318","journal-title":"Lung Cancer"},{"key":"1501_CR9","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542\u20132550","journal-title":"N Engl J Med"},{"key":"1501_CR10","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543\u20133551","journal-title":"J Clin Oncol"},{"key":"1501_CR11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M (2009) Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947\u2013957","journal-title":"N Engl J Med"},{"key":"1501_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Munoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13:239\u2013246","journal-title":"Lancet Oncol"},{"key":"1501_CR13","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Janne PA (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368:2385\u20132394","journal-title":"N Engl J Med"},{"key":"1501_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","volume":"25","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N (2012) p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 25:405\u2013415","journal-title":"Mod Pathol"},{"key":"1501_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAS.0b013e3182036d05","volume":"35","author":"S Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay S, Katzenstein AL (2011) Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5\/6. Am J Surg Pathol 35:15\u201325","journal-title":"Am J Surg Pathol"},{"key":"1501_CR16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/JTO.0b013e31823815d3","volume":"7","author":"G Pelosi","year":"2012","unstructured":"Pelosi G, Fabbri A, Bianchi F, Maisonneuve P, Rossi G, Barbareschi M, Graziano P, Cavazza A, Rekhtman N, Pastorino U, Scanagatta P, Papotti M (2012) DeltaNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J Thorac Oncol 7:281\u2013290","journal-title":"J Thorac Oncol"},{"key":"1501_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1066896913476750","volume":"21","author":"G Pelosi","year":"2013","unstructured":"Pelosi G, Rossi G, Cavazza A, Righi L, Maisonneuve P, Barbareschi M, Graziano P, Pastorino U, Garassino M, de Braud F, Papotti M (2013) DeltaNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol 21:229\u2013239","journal-title":"Int J Surg Pathol"},{"key":"1501_CR18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/modpathol.2011.92","volume":"24","author":"N Rekhtman","year":"2011","unstructured":"Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL (2011) Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mod Pathol 24:1348\u20131359","journal-title":"Mod Pathol"},{"key":"1501_CR19","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1200\/JCO.2009.24.0515","volume":"27","author":"G Rossi","year":"2009","unstructured":"Rossi G, Papotti M, Barbareschi M, Graziano P, Pelosi G (2009) Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer. J Clin Oncol 27:e141\u2013e142, author reply e143\u20134","journal-title":"J Clin Oncol"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1066896909336178","volume":"17","author":"G Rossi","year":"2009","unstructured":"Rossi G, Pelosi G, Graziano P, Barbareschi M, Papotti M (2009) A reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Int J Surg Pathol 17:206\u2013218","journal-title":"Int J Surg Pathol"},{"key":"1501_CR21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1066896913489346","volume":"21","author":"G Rossi","year":"2013","unstructured":"Rossi G, Pelosi G, Barbareschi M, Graziano P, Cavazza A, Papotti M (2013) Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. Int J Surg Pathol 21:326\u2013336","journal-title":"Int J Surg Pathol"},{"key":"1501_CR22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1309\/AJCPYY79XAGRAYCJ","volume":"136","author":"M Barbareschi","year":"2011","unstructured":"Barbareschi M, Cantaloni C, Del Vescovo V, Cavazza A, Monica V, Carella R, Rossi G, Morelli L, Cucino A, Silvestri M, Tirone G, Pelosi G, Graziano P, Papotti M, Dalla Palma P, Doglioni C, Denti MA (2011) Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol 136:773\u2013782","journal-title":"Am J Clin Pathol"},{"key":"1501_CR23","doi-asserted-by":"crossref","unstructured":"Hwang DH, Szeto DP, Perry AS, Bruce JL, Sholl LM (2013) Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma. Arch Pathol Lab Med","DOI":"10.5858\/arpa.2013-0179-OA"},{"key":"1501_CR24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/modpathol.2009.30","volume":"22","author":"V Monica","year":"2009","unstructured":"Monica V, Ceppi P, Righi L, Tavaglione V, Volante M, Pelosi G, Scagliotti GV, Papotti M (2009) Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Mod Pathol 22:709\u2013717","journal-title":"Mod Pathol"},{"key":"1501_CR25","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/1078-0432.CCR-09-1641","volume":"15","author":"V Monica","year":"2009","unstructured":"Monica V, Scagliotti GV, Ceppi P, Righi L, Cambieri A, Lo Iacono M, Saviozzi S, Volante M, Novello S, Papotti M (2009) Differential thymidylate synthase expression in different variants of large-cell carcinoma of the lung. Clin Cancer Res 15:7547\u20137552","journal-title":"Clin Cancer Res"},{"key":"1501_CR26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAI.0b013e31819bfd59","volume":"17","author":"J Pardo","year":"2009","unstructured":"Pardo J, Martinez-Penuela AM, Sola JJ, Panizo A, Gurpide A, Martinez-Penuela JM, Lozano MD (2009) Large cell carcinoma of the lung: an endangered species? Appl Immunohistochem Mol Morphol 17:383\u2013392","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1501_CR27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2012.195","volume":"26","author":"N Rekhtman","year":"2013","unstructured":"Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M (2013) Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Mod Pathol 26:511\u2013522","journal-title":"Mod Pathol"},{"key":"1501_CR28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1309\/9W8D3XCVLRA3858A","volume":"122","author":"G Rossi","year":"2004","unstructured":"Rossi G, Marchioni A, Milani M, Scotti R, Foroni M, Cesinaro A, Longo L, Migaldi M, Cavazza A (2004) TTF-1, cytokeratin 7, 34betaE12, and CD56\/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol 122:884\u2013893","journal-title":"Am J Clin Pathol"},{"key":"1501_CR29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1309\/AJCPH0TRMPXVZW2F","volume":"131","author":"G Sartori","year":"2009","unstructured":"Sartori G, Cavazza A, Sgambato A, Marchioni A, Barbieri F, Longo L, Bavieri M, Murer B, Meschiari E, Tamberi S, Cadioli A, Luppi F, Migaldi M, Rossi G (2009) EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors. Am J Clin Pathol 131:478\u2013489","journal-title":"Am J Clin Pathol"},{"key":"1501_CR30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/jcp.2011.090571","volume":"64","author":"EC McLean","year":"2011","unstructured":"McLean EC, Monaghan H, Salter DM, Wallace WA (2011) Evaluation of adjunct immunohistochemistry on reporting patterns of non-small cell lung carcinoma diagnosed histologically in a regional pathology centre. J Clin Pathol 64:1136\u20131138","journal-title":"J Clin Pathol"},{"key":"1501_CR31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/JTO.0b013e31820b9e0e","volume":"6","author":"G Rossi","year":"2011","unstructured":"Rossi G, Cavazza A (2011) Histologic type definition in clinical trials on advanced non-small cell lung cancer. J Thorac Oncol 6:405","journal-title":"J Thorac Oncol"},{"key":"1501_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0046-8177(78)80105-1","volume":"9","author":"A Churg","year":"1978","unstructured":"Churg A (1978) The fine structure of large cell undifferentiated carcinoma of the lung. Evidence for its relation to squamous cell carcinomas and adenocarcinomas. Hum Pathol 9:143\u2013156","journal-title":"Hum Pathol"},{"key":"1501_CR33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1378\/chest.90.4.524","volume":"90","author":"VC Delmonte","year":"1986","unstructured":"Delmonte VC, Alberti O, Saldiva PH (1986) Large cell carcinoma of the lung\u2014ultrastructural and immunohistochemical features. Chest 90:524\u2013527","journal-title":"Chest"},{"key":"1501_CR34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/1097-0142(19800301)45:5<943::AID-CNCR2820450518>3.0.CO;2-7","volume":"45","author":"AL Katzenstein","year":"1980","unstructured":"Katzenstein AL, Prioleau PG, Askin FB (1980) The histologic spectrum and significance of clear-cell change in lung carcinoma. Cancer 45:943\u2013947","journal-title":"Cancer"},{"key":"1501_CR35","first-page":"19","volume":"1","author":"D Tan","year":"2008","unstructured":"Tan D, Zander DS (2008) Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. Int J Clin Exp Pathol 1:19\u201331","journal-title":"Int J Clin Exp Pathol"},{"key":"1501_CR36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/JTO.0b013e318219ac78","volume":"6","author":"K Tsuta","year":"2011","unstructured":"Tsuta K, Tanabe Y, Yoshida A, Takahashi F, Maeshima AM, Asamura H, Tsuda H (2011) Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J Thorac Oncol 6:1190\u20131199","journal-title":"J Thorac Oncol"},{"key":"1501_CR37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PAI.0b013e31802d1590","volume":"15","author":"MR Peterson","year":"2007","unstructured":"Peterson MR, Piao Z, Bazhenova LA, Weidner N, Yi ES (2007) Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFR immunoreactivity and EGFR mutations. Appl Immunohistochem Mol Morphol 15:242\u2013247","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1501_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10555-010-9205-8","volume":"29","author":"Y Yatabe","year":"2010","unstructured":"Yatabe Y (2010) EGFR mutations and the terminal respiratory unit. Cancer Metastasis Rev 29:23\u201336","journal-title":"Cancer Metastasis Rev"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1501-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1501-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:36:11Z","timestamp":1559064971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1501-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1501-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}